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SUMMARY STATEMENT 
Ocular albinism may be mistaken for other disorders associated with congenital 
nystagmus. We identify features of ocular albinism, present in female carriers that 
will help facilitate an accurate diagnosis. 
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Abstract 
 
Introduction 
Albinism refers to a group of disorders primarily characterised by hypopigmentation. 
Affected individuals usually manifest both ocular and cutaneous features of the 
disease,  but occasionally hair and skin pigmentation may appear normal. This is the 
case in ocular albinism, an X chromosome linked disorder resulting from mutation 
of GPR143. Female carriers may be recognised by a "mud-splatter" appearance in 
the peripheral retina. The macula is thought to be normal however. 
 
Methods 
Obligate female carriers of pathogenic GPR143 alleles were recruited. Molecular 
confirmation of disease was performed only for atypical cases. Detailed retinal 
imaging was performed (colour fundus photography, optical coherence tomography 
(OCT), fundus autofluorescence (FAF)). 
 
Results 
8 individuals were ascertained. A novel GPR143 mutation was identified in one 
family (p.Gln328Ter). Foveal FAF was subjectively reduced in 6/6 patients imaged. A 
"tapetal-like" pattern of autofluorescence was visible at the macula in 3/6. 
Persistence of the inner retinal layers at the fovea was observed in 6/8 females. 
 
Conclusions 
Female carriers of ocular albinism manifest sign of RPE mosaicism at the macula as 
well as the peripheral fundus. A tapetal-like reflex on FAF may be considered the 
macular correlate of "mud-splatter". 
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Title: Detailed retinal imaging in carriers of ocular albinism. 
Introduction 
 
Albinism, from the latin, albus (white), represents a range of inherited, congenital 
disorders of hypomelanosis, typically involving the skin, hair and eyes.  The 
phenotype may be highly variable. In the most extreme cases there is little or no 
melanin production, whilst milder forms are associated with greater levels of 
pigmentation.1 Melanin granules are found in dermal and follicular melanosomes, in 
addition to melanosomes of the iris, retinal pigment epithelium (RPE) and choroidal 
stroma.2In most cases, clinical signs are present in all these tissues; these patients 
are diagnosed as having oculocutaneous albinism (OCA).1In the mildest cases, signs 
may only be identifiable in the eye, as this appears to be the structure most sensitive 
to pigment dosage. Where the clinical signs are limited to the eye, the term ocular 
albinism (OA) is used.3Very rarely, albinism may be associated with additional 
syndromic features, leading to a diagnosis of Chediak-Higashi (CHS, OMIM 214500) 
or Hermasky-Pudlack Syndromes(HPS, OMIM 203300, 608233). Other systemic 
disorders associated with hypomelanosis (also described historically as “partial 
albinism”) include Griscelli Syndrome (GS, OMIM 414450, 607624), Elejalde disease 
(ED, OMIM 256710) and Tietz syndrome (OMIM 103500, 156845). These disorders 
share dysfunction in exocytosis pathways, affecting not only the release of pigment 
granules but also key components of the clotting cascade from platelets (HPS), 
lysosomal trafficking (CHS) and cytotoxic granule release from immune cells (GS). 
 
The OA phenotype is associated with both autosomal recessive and X-linked 
inheritance.4, 5It is likely to represent the “tip of the iceberg”, as in addition to major 
signs that may only be apparent in the eye, subclinical endophenotypes are found in 
the hair and skin; accordingly it should be thought of as a systemic disease.6 The 
most common form of OA is OA type 1 (OA1, OMIM 300500), transmitted as an X-
linked disorder resulting from mutation ofGPR143(OA1,NM_000273).7GPR143 
encodes a G-protein coupled receptor present in late endosomes, lysosomes, and 
early stage melanosomes.8Affected males exhibit the classical ocular features of 
albinism – reduced visual acuity, nystagmus, foveal hypoplasia, iris transillumination 
defects, reduced fundus pigmentation and chiasmal misrouting, but few if any extra-
ocular signs, particularly in well-pigmented ethnic groups.9When carefully compared 
to unaffected siblings subtle signs of cutaneous hypomelanosis may be evident.6The 
identification of macromelanosomes on skin biopsy confirms that this is indeed a 
global disorder of melanisation.10-12 
 
Females heterozygous for GPR143 mutations are usually asymptomatic, although 
signs of carrier status are often present, with a characteristic pattern of 
depigmentation evident in the iris (transillumination defects) and retinal pigment 
epithelium (“mud splatter appearance”).13, 14Macular changes however are poorly 
described. The present work represents a prospective, consecutive case series 
describing the macular changes present in mothers of male probands with OA. 
 
 
Methods 
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Individuals diagnosed as carriers of X-linked OA, and mothers of boys with OA were 
recruited from the inherited retinal disease (IRD) clinics at Moorfields Eye Hospital, 
London, UK. Clinical examinations were performed by one of four retina physicians 
experienced in managing patients with IRD (ATM, MM, ARW, KNK). Participants were 
assessed using slit lamp biomicroscopy, color fundus photography (CFP), spectral 
domain optical coherence tomography (OCT) and 488nm wavelength fundus 
autofluorescence (FAF) (both Spectralis, Heidelberg Engineering, Heidelberg). Visual 
acuity was measured at 6 meters with a Snellen chart. For atypical cases, molecular 
genetic confirmation was obtained after whole exome or whole genome sequencing, 
either as a participant in the NIHR BioResource – Rare Diseases project or an in-
house sequencing study (see Supplementary Methods). Segregation of variants 
identified by whole-exome and whole genome sequencing was performed by 
polymerase chain reaction and Sanger sequencing using standard protocols.15 
Primers were designed using ExonPrimer16 and can be found in Supplementary Table 
1.As a control group, mothers of children with OCA were also recruited to this study. 
They also underwent detailed retinal imaging but no genetic investigations were 
performed. All participants provided informed consent, and research adhered to the 
principles set out in the Declaration of Helsinki (2013). 
 
 
Results 
 
Eight females were recruited. Four were ascertained at their affected son’s hospital 
appointment. Two were referred directly, as their optometrist identified pigmentary 
changes at routine assessment. Two were examined as part of a family survey. In all 
cases there was at least one additional male relative known to have OA. No families 
had any affected female family members. The clinical and molecular features are 
described in Table 1 and Figures 1-3.  
 
In only one case was a reduction in vision recorded, which was lifelong and non-
progressive (Case1a). Iris transillumination was present in all female carriers; these 
defects were clearly visible in the mid to peripheral iris, but were never seen 
immediately adjacent to the pupillary margin. Nystagmus was never observed. 
Retinal examination revealed a radial pattern of pigmentation in the peripheral 
retina consistent with “mud-splatter” (8/8). 
 
Fundus Autofluorescence 
 
The FAF images demonstrated subtle alterations in retinal autofluorescence in all 
cases where imaging was obtained (6/8).The central zone of hypoautofluorescence 
was reduced in size, in keeping with reduced luteal pigment (Figures1a and2). 
Immediately adjacent to this an irregular pattern of autofluorescence was observed 
in the peripheral macula, and in three cases(Cases 1b, 1c and 6) this manifested as a 
prominent radiating pattern of hyperautofluorescence, in a tapetal-like reflex 
fashion, not visible by near infrared reflectance imaging (Figure 2) or color fundus 
photography(Figure 3a). Where visualised, peripheral retinal autofluorescence was 
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characterised by radial patches of relative hypoautofluorescence, corresponding 
with the observed streaks of relative hyperpigmentation in these regions (Figure 2 
and 3c).For one mother the tapetal-like reflex appeared to extend into the 
peripheral retina (Case 6). 
 
Optical Coherence Tomography 
 
In 6/8 cases, persistence of the inner retinal layers was observed (Figure 1c).Despite 
this, a change in contour of the third highly reflective OCT line (ellipsoid zone) was 
always visible at the foveola, consistent with physiological lengthening of the cone 
outer segments. The center of the fovea was always avascular. As a surrogate 
marker of macular pigmentation, the visibility of the sub-foveal sclero-choroidal 
boundary was recorded (Figure 1c). This junction was clearly visible in 5/8 mothers. 
Unusually for one mother (Case 1a) this boundary was easily identifiable despite a 
choroidal thickness of greater than 500μm.In 3/8 cases (6 eyes),the boundary 
between the choroid and sclera was invisible; here the choroidal thickness was 
estimated to be greater than 350μm.Two mothers had a normal foveal contour, 
without persistence of the inner retinal layers.  
 
Genetics 
 
For two families where there was uncertainty regarding the diagnosis molecular 
genetic testing was initiated. Retinal examination in Case 4’s sonwas limited by his 
age and nystagmus velocity, and the results of electrophysiological testingto assess 
chiasmal misrouting was equivocal. Case 1a’s visual acuity was subnormal, and as 
her full field electroretinogram identified possible rod system dysfunction, a clinical 
diagnosis of OA carrier remained questionable.  
 
In both cases, after bioinfomatic filtering and prioritising genes already implicated in 
retinal disease17 only variants in GPR143 remained as a possible cause of disease. 
Family 1 (Cases1a-c) harbored a previously identified pathogenic variant, 
p.Trp292Gly, sufficient to account for their retinal findings.18 Testing the son of Case 
4identified a novel null allele(p.Gln328Ter). Sanger sequencing confirmed each 
variant, and its segregation with the disease phenotype. In both cases the mothers 
were heterozygous for the mutation. 
 
Control group 
 
In order to determine how specific the above findings are, five mothers of children 
with OCA were also examined. All were asymptomatic and had normal visual acuity 
(6/6). No fundus abnormalities were detected with CFP, FAF or OCT. Representative 
images are shown in Figure 1. 
 
 
Discussion 
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In this study we have identified novel clinical features associated with carrier status 
of ocular albinism– persistence of the retinal ganglion cell layer at the fovea, reduced 
foveal hypoautofluorescence, and irregular peripheral macular autofluoresence. In 
this study these features were present in the majority of cases, and almost always 
associated with excellent vision. As recognizing rare disorders may be difficult, these 
easy to detect clinical featuresshould help facilitate a prompt and accurate diagnosis, 
both for carriers of OA and by inference their affected male children.  
 
Hypomelanosisis thought to occur as a result of random X-chromosome inactivation. 
Unlike the variable asymmetrical scattered mosaic appearance observed in carriers 
of CHM(choroideremia) and RPGR/RP2(rod-cone and cone-rod dystrophy) 
mutations, stereotyped pigmentary changes occur in carriers of X-linked OA- radial 
streaks of relative hyperpigmentation seen adjacent to lines of hypopigmentation, 
commonly referred to as “mud-splatter”.14, 19This reproducible finding however is 
seemingly not in keeping with a random event. As X-chromosome inactivation occurs 
as an independent event in each cell of the developing blastocyst, a continuous 
streak of hypopigmented cells should not occur by chance, as this would require 
aconsecutive series of hundreds of adjacent cells to each inactivate the same X-
chromosome.19A more parsimonious explanation is that all RPE cells in a streak of 
hypopigmentation derive from a common RPE progenitor, with the same X-
chromosome inactivated. The pattern seen may therefore bean observation of the 
migration pattern of developing RPE cells, preprogrammed to either express the 
mutant or wild-type protein. This phenotype may be thought of as the ocular 
equivalent of Blashko’s lines, alternating swirls of hyperpigmented and normally 
pigmented skin cells which occur in a range of dermatological conditions.20 
 
To date macular changes have not been described in carriers of OA, as “mud 
splatter” is considered a phenomenon of the peripheral retina. Even in the most 
extreme cases of albinism the macula rarely appears depigmented, suggesting that 
either these cells are relatively spared or that other pigmented structures are well 
preserved. Melanin granules reside within the RPE and choroidal stroma. In their 
absence, the fundus has a blonde hue, representing the color of light reflected from 
the sclera, filtered by a depigmented RPE and retina. Macula anatomy differs from 
that in the peripheral retina, with a greater density of RPE cells and a thicker 
choroid, both factors that would result in significant residual pigmentation. The 
choroidal so contains significant numbers of erythrocytes, adding further color. 
Lastly, luteal pigments, lutein and zeaxanthin are stored here too. A reduction in 
melanin content will therefore remain relatively disguised at the macula and more 
apparent in the periphery where the retina, RPE and choroid are thinnest. 
 
Using multimodal imaging this study has identified three novel characteristic traits 
identified in female carriers of OA. Firstly, using 488nm FAF imaging, linear streaks, 
described as a “tapetal-like” reflex, are visible at the macula of two sisters (Cases 1b 
and 1c) and a third unrelated mother (Case6). This finding is thought to be unique to 
female carriers of X-linked retinitis pigmentosa (XLRP), however no variants in RPGR 
or RP2 were identified after whole exome sequencing (Cases 1b and 1c).These 
individuals would therefore represent the first report of a tapetal-like reflex in 
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association with OA, a finding that may represent the macular correlate of “mud-
splatter”(Figure 2).As this appearance is more commonly seen in patients with 
primary photoreceptor disease it may seem curious as to why the migratory patterns 
of embryonic RPE cells influence the expression of a photoreceptor disease. One 
explanation may relate to the interaction between these cells, as randomly 
distributed dysfunctional photoreceptors may only influence susceptible clones of 
RPE cells, themselves distributed in a non-random, radial manner. 
 
Secondly, the central zone of physiological hypoautofluorescence appears to be 
reduced in size in comparison to healthy controls (Figure 1a). Although normal 
macular autofluorescence may show significant inter-individual variation, thought to 
relate to the distribution of macular pigments, all cases tested (10 eyes) shared the 
phenotype of a single small zone of reduced autofluorescence. Taken in isolation this 
may have been a chance occurrence, however in conjunction with other structural 
changes this is likely to be a further biomarker of carrier status. 
 
Thirdly, 6/8female carriers demonstrated subtle persistence of the retinal ganglion 
cell (RGC) layer at the fovea, without clinical evidence of foveal vascularization or 
loss of acuity. This suggests that maturation of the inner retina may be the structure 
most sensitive to loss of melanin. In 2/8 cases where RGCs were absent from the 
fovea, the posterior choroidal boundary was also not visible, perhaps suggesting that 
eyes with more melanin are less likely to show signs of foveal immaturity. As the 
fovea may sustain excellent acuity even when vascularized, one may now impute a 
hierarchy for sensitivity to melanisation. Subtle loss of pigment results in foveal RGC 
persistence, greater loss of melanin results in RGC persistence alongside foveal 
vascularity (but good vision), and the most severe end of the spectrum is a “full 
house” of signs – persistence of the inner retinal layers/absence of a foveal pit, 
foveal vascularization, and central macular dysfunction (loss of acuity). 
Heterozygosity for OA variants may therefore alter macular melanisation minimally, 
associated with clinical findings of normal acuity and macular anatomy (1/8 here), 
whilst in others it may be associated with subtle persistence of foveal RGC (6/8 
cases).Rarely, in more extreme cases (1/8 here),foveal hypoplasia and reduced visual 
acuity may be noted. 
 
A detailed eye examination is often extremely helpful when determining the 
inheritance pattern for genetic disorders, particularly those inherited in an X-linked 
manner. Clinical findings of carrier status have been reported both for eye disease as 
well as systemic disorders (Table 2). Carrier status may not always be associated with 
overt clinical signs, as mothers of boys with X-linked retinoschisis (XLRS; OMIM 
312700) and congenital stationary night blindness (OMIM 310500, 300071) have a 
normal retinal appearance. It may be however that more sensitive forms of testing 
reveal subtle signs of dysfunction (e.g. Frumke effect detected by psychophysical 
testing in XLRS carriers).21To date clinical findings in female carriers of OA have been 
variable, as most reports suggest that female carriers have no OCT or FAF 
abnormalities, however others describe significant changes.22-24This discrepancy may 
in part relate to uncertainty regarding the pattern of inheritance, as autosomal 
recessive disease may masquerade as XLOA in the absence of a molecular 
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diagnosis.25 The inability to identifyGPR143mutations similarly doesn’t exclude this 
as a cause of disease, as the screening technique will determine the detection 
sensitivity which varies between 35-90%.18, 26-29It appears less likely that novel genes 
are responsible for this low sensitivity, as linkage analysis in pedigrees with no 
identifiable pathogenic variants in GPR143 still maps the disease to this locus.18, 26, 
29Unsurprisingly, intronic variants in GPR143have now been associated with 
disease.30 Other potential reasons for the variation in the clinical findings not 
controlled for in this study are chromosomal anomalies (Turner syndrome or 
variations thereof) and skewed X chromosome inactivation.  
 
In summary, multimodal imaging in female carriers of OA demonstrates 
abnormalities of macular as well as peripheral retinal development. These patterns 
are likely to occur as a result of early X-chromosome inactivation, where clones of 
RPE cells all express the same X-chromosome. These novel findings will provide 
additional diagnostic clues for clinicians, and allow vision researchers to better 
understand the in vivo migration of human RPE cells. 
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Figure Legends 
Figure 1. Typical retinal changes in female carriers of ocular albinism (OA) and 
oculocutaneous albinism (OCA) as detected by multimodal imaging. (a) 488nm 
fundus autofluorescence demonstrating a smaller than normal zone of physiological 
hypoautofluorescence in Case 4, (b) near infrared reflectance appears normal, whilst 
(c) optical coherence tomography scans through the fovea identify persistence of the 
inner retinal layers in Case 4. Similar changes were not evident in five obligate 
female carriers of (recessive) OCA alleles.  
 
Figure 2. Multimodal macular imaging in three female carriers of ocular albinism. For 
each patient images of the right and left eyes are shown, with 488nm fundus 
autofluorescence (FAF) (top) and near infrared reflectance (NIR-R) (bottom). These 
three individuals have a radially distributed bright reflex, centered on the fovea, 
apparent on FAF but not NIR-R imaging. For Case 6, where 55° widefield imaging is 
available, this reflex is seen to extend into the peripheral retina. 
 
 
Figure 3. Widefield imaging in female carriers of ocular albinism. (a) A montage of 
color fundus photographs from Case 1b demonstrating absence of the tapetal-like 
reflex seen in Figure 2, and peripheral streaks of hypopigmentation. (b) Optos 
widefield pseudocolor and (c) green laser autofluorescence imaging in Case 6 
similarly identifies peripheral streaks of reduced pigmentation and increased 
autofluorescence signal.  
